Initiation of noninsulin second-line Antidiabetics fraught with risk of discontinuation within one year: Study
USA: Adherence to second-line diabetes drugs can be hit or miss among patients with type 2 diabetes, a recent study has reported. The findings published in the American Journal of Managed Care showed that two-thirds of patients discontinued their medication, switched to a different medication class or intensified their treatment. Discontinuation was higher (50%) among […]